James B Breitmeyer insider trades

Open-market stock purchases and sales by James B Breitmeyer, Director at Vaxart, Inc, from SEC Form 4 filings since Jan 5, 2010.

Track record: 75% of 4 scored buys are up 5% or more since purchase, averaging +43%.

Recent trades

DateStockTradeValue
Jul 16, 2026VXRT Vaxart, IncBought (not open market)—
Jul 16, 2026VXRT Vaxart, IncBought (not open market)—
Apr 23, 2026VXRT Vaxart, IncBought (not open market)—
Apr 23, 2026VXRT Vaxart, IncBought (not open market)—

Companies traded

  • VXRT Vaxart, Inc: other filings, last Jul 16, 2026
  • ONCT Oncternal Therapeutics, Inc: 4 buys, last Feb 14, 2024
  • OTIC Otonomy, Inc: other filings, last Jun 21, 2022
  • ZGNX Zogenix, Inc: 2 sales, last Mar 7, 2022
  • CADX Cadence Pharmaceuticals Inc: 14 sales, last Mar 14, 2012

Get free alerts when James B Breitmeyer files a new trade →